Bridgeway Capital Management’s AdaptHealth AHCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.3M Sell
987,761
-18,543
-2% -$207K 0.18% 173
2026
Q1
$12M Buy
1,006,304
+8,602
+0.9% +$88K 0.24% 126
2025
Q4
$9.94M Sell
997,702
-15,696
-2% -$150K 0.21% 144
2025
Q3
$9.07M Sell
1,013,398
-128,979
-11% -$1.19M 0.19% 156
2025
Q2
$10.8M Sell
1,142,377
-159,289
-12% -$1.41M 0.26% 114
2025
Q1
$14.1M Sell
1,301,666
-22,377
-2% -$225K 0.36% 68
2024
Q4
$12.6M Buy
1,324,043
+283,143
+27% +$2.87M 0.28% 104
2024
Q3
$11.7M Buy
1,040,900
+29,078
+3% +$309K 0.25% 119
2024
Q2
$10.1M Buy
1,011,822
+4,060
+0.4% +$41.3K 0.24% 123
2024
Q1
$11.6M Buy
1,007,762
+38,084
+4% +$323K 0.24% 123
2023
Q4
$7.07M Sell
969,678
-7,969
-0.8% -$62.8K 0.15% 209
2023
Q3
$8.9M Buy
977,647
+34,760
+4% +$417K 0.22% 132
2023
Q2
$11.5M Buy
+942,887
New +$10.5M 0.27% 84

Other funds holding AHCO

Bridgeway Capital Management's AHCO Position: Q2 2026 in Review

Bridgeway Capital Management reduced its AdaptHealth (AHCO) stake by 1.8% in Q2 2026, selling an estimated $207K and leaving 987,761 shares worth $10.3M. The position accounts for 0.18% of the portfolio, ranked #173.

Bridgeway Capital Management first reported a position in AHCO in Q2 2023 and has held it in 13 quarters since. The position peaked at $14.1M in Q1 2025. 238 funds tracked by Wall St. Rank hold AHCO as of Q2 2026.

  • Bridgeway Capital Management held 987,761 shares of AdaptHealth worth $10.3M as of Q2 2026.
  • Bridgeway Capital Management sold 18,543 AdaptHealth shares in Q2 2026, an estimated $207K.
  • AdaptHealth made up 0.18% of Bridgeway Capital Management's portfolio in Q2 2026, its #173 holding.
  • Bridgeway Capital Management first reported a position in AdaptHealth in Q2 2023 and has held it in 13 quarters since.
  • Bridgeway Capital Management's AdaptHealth position peaked at $14.1M in Q1 2025.
  • 238 funds tracked by Wall St. Rank held AdaptHealth as of Q2 2026.

Based on Bridgeway Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.